Prevalence and Characterization of MET Overexpression in Chinese NSCLC Patients: A Retrospective Real-World Analysis

被引：0
|
作者：
Yang, L. [1 ]
Li, J. [1 ]
Li, Y. [1 ,2 ]
Lin, R. [1 ]
Li, Y. [1 ,2 ]
Chen, J. [1 ]
Lai, X. [1 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
MET overexpression; adenocarcinomas;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.04E.05
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [1] Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
    Ai, Xinghao
    Yu, Yongfeng
    Zhao, Jun
    Sheng, Wang
    Bai, Jing
    Fan, Zaiwen
    Liu, Xuemei
    Ji, Wenxiang
    Chen, Rongrong
    Lu, Shun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [2] The treatment pattern and clinical outcome in NSCLC patients with MET alteration: A retrospective real-world analysis in China
    Yu, Y.
    Shen, L.
    Li, W.
    Jin, B.
    Xia, Y.
    Zhang, S.
    Lu, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1702 - S1702
  • [3] Real-world insights into patients with advanced NSCLC and MET alterations
    Bittoni, Marisa
    Yang, James Chih-Hsin
    Shih, Jin-Yuan
    Peled, Nir
    Smit, Egbert F.
    Camidge, D. Ross
    Arasada, Rajeswara Rao
    Oksen, Dina
    Boutmy, Emmanuelle
    Stroh, Christopher
    Johne, Andreas
    Carbone, David P.
    Paik, Paul K.
    LUNG CANCER, 2021, 159 : 96 - 106
  • [4] Real-world insights into patients (pts) with advanced NSCLC and MET alterations
    Bittoni, M.
    Yang, J. C-H.
    Shih, J-Y.
    Peled, N.
    Smit, E.
    Camidge, R.
    Carbone, D.
    Oksen, D.
    Boutmy, E.
    Johne, A.
    Paik, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1398 - S1399
  • [5] Sugemalimab in locally advanced and advanced Chinese NSCLC: A real-world retrospective study
    Liu, Jiayu
    Wang, Yan
    Wang, Qi
    Yang, Ke
    Xie, Tongji
    Sun, Dantong
    Wu, Lige
    Li Junling
    Xing, Puyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study
    Su, Jun-Wei
    Weng, Cheng-Di
    Lin, Xiao-Cheng
    Fang, Mei-Mei
    Xiao, Xiao
    Zhang, Yi-Chen
    Zhang, Xu-Chao
    Su, Jian
    Xu, Chong-Rui
    Yan, Hong-Hong
    Chen, Hua-Jun
    Wu, Yi-Long
    Yang, Jin-Ji
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [7] Real-world (rw) analysis of quantitative MET copy number (CN) as a biomarker in NSCLC.
    Tsui, David Chun Cheong
    Lee, Jessica Kim
    Frampton, Garrett M.
    Tolba, Khaled
    Oxnard, Geoffrey R.
    Camidge, D. Ross
    Schrock, Alexa Betzig
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Exploring practical experience with different treatments in NSCLC patients with MET-deregulated: a retrospective analysis from the real world
    Li, Mengmeng
    Huang, Jiuyan
    Xing, Ruyue
    Du, Xinyang
    Wei, Chunhua
    Wang, Huijuan
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [9] Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study
    Greystoke, A.
    Nawaz, A.
    Ferguson, S.
    Pabla, M.
    Sanjeevi, P.
    Bar-Ziv, O.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S299 - S300
  • [10] Characterization of MET Overexpression (OE) and Impact on Prognosis in a Real-World, Single-Site Cohort of Patients with Nonsquamous Non-Small-Cell Lung Cancer (NSq NSCLC)
    Parvani, J.
    Bar, J.
    Cai, M.
    Choi, Y.
    Baijal, S.
    Zhao, W.
    Liede, A.
    Raskin, L.
    Vasilopoulos, A.
    Li, M.
    Roberts-Rapp, L.
    Jiang, F.
    Ratajczak, C.
    Lu, S.
    Ansell, P.
    Camidge, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S119 - S119
12345